FDA and Defense Dept to share data

12 August 2007

Data from the USA's Military Health System will soon help the nation's Food and Drug Administration make decisions affecting the safety and use of FDA-regulated products for all Americans, the latter revealed. The FDA and the Department of Defense have announced a partnership to share data and expertise related to the review and use of agency-regulated drugs, biologics and medical devices.

General patient data such as prescriptions, laboratory results and people's weight will be used by the FDA to spot trends, which may identify potential concerns, as well as recognize the benefits of medicinal products. The two agencies say they will protect all personal health information exchanged under the agreement, in accordance with federal law.

The "FDA is privileged to collaborate with DoD to protect the health of all Americans," said Commissioner of Food and Drugs Andrew von Eschenbach, noting that "the opportunity to create systems to monitor the safety of products should directly benefit those cared for by the armed services as well as many others."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight